PandemieGrippaleV1, PascalFrancis, Corpus, bibRecord, 000308

Neonatal Outcomes After Antenatal Influenza Immunization During the 2009 H1N1 Influenza Pandemic: Impact on Preterm Birth, Birth Weight, and Small for Gestational Age Birth

Identifieur interne : 000308 ( PascalFrancis/Corpus ); précédent : 000307; suivant : 000309

Neonatal Outcomes After Antenatal Influenza Immunization During the 2009 H1N1 Influenza Pandemic: Impact on Preterm Birth, Birth Weight, and Small for Gestational Age Birth

Auteurs : Jennifer L. Richards ; Craig Hansen ; Christine Bredfeldt ; Robert A. Bednarczyk ; Mark C. Steinhoff ; Dzifa Adjaye-Gbewonyo ; Kevin Ault ; Mia Gallagher ; Walter Orenstein ; Robert L. Davis ; Saad B. Omer

Source :

Clinical infectious diseases [ 1058-4838 ] ; 2013.

RBID : Pascal:13-0157683

Descripteurs français

Pascal (Inist)
- Hypotrophie foetale, Poids de naissance faible, Nouveau né, Pronostic, Immunisation, Vaccination, Prématurité, Accouchement prématuré, Poids naissance, Naissance, Infection, Pandémie, Grippe H1N1.

English descriptors

KwdEn :
- Birth, Birth weight, H1N1 influenza, Immunization, Infection, Intrauterine growth retardation, Low birth weight, Newborn, Premature delivery, Prematurity, Prognosis, Vaccination.

Abstract

Background. Influenza infection during pregnancy is associated with adverse fetal outcomes such as preterm birth and small for gestational age (SGA). Maternal influenza immunization may prevent these adverse infant outcomes during periods of influenza circulation. Methods. We conducted a retrospective cohort study of live births within Kaiser Permanente (KP) Georgia and Mid-Atlantic States (n = 3327) during the period of 2009 influenza A (H1N1) virus circulation. Primary outcomes were third-trimester preterm birth (27-36 weeks), birth weight, low birth weight (LBW, <2500 g), and SGA. Results. There were 327 (9.8%) preterm, 236 (7.4%) LBW, and 267 (8.4%) SGA births. Among H1N1-vaccinated mothers (n = 1125), there were 86 (7.6%) preterm, 68 (6.4%) LBW, and 99 (9.3%) SGA births, and the mean birth weight was 3308.5 g (95% confidence interval [CI], 3276.6-3340.4). Among unvaccinated mothers (n = 1581), there were 191 (12.1%) preterm, 132 (8.8%) LBW, and 123 (8.2%) SGA births, and the mean birth weight was 3245.3 g (95% CI, 3216.5-3274.2). Infants of H1N1-vaccinated mothers had 37% lower odds of being born preterm than infants of unvaccinated mothers (adjusted odds ratio, 0.63 [95% CI, .47-.84]). The mean birth weight difference between infants of H1N1-vaccinated mothers and infants of unvaccinated mothers was 45.1 g (95% CI, 1.8-88.3). There was no significant association between maternal H1N1 influenza immunization and LBW or SGA. Conclusions. Pregnant women who received H1N1 influenza vaccine were less likely to give birth preterm, and gave birth to heavier infants. The findings support US vaccine policy choices to prioritize pregnant women during the 2009 influenza A (H1N1) pandemic.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 1058-4838`
A02	`01`			`@0 CIDIEL`
A03		`1`		`@0 Clin. infect. dis.`
A05				`@2 56`
A06				`@2 9`
A08	`01`	`1`	`ENG`	`@1 Neonatal Outcomes After Antenatal Influenza Immunization During the 2009 H1N1 Influenza Pandemic: Impact on Preterm Birth, Birth Weight, and Small for Gestational Age Birth`
A11	`01`	`1`		`@1 RICHARDS (Jennifer L.)`
A11	`02`	`1`		`@1 HANSEN (Craig)`
A11	`03`	`1`		`@1 BREDFELDT (Christine)`
A11	`04`	`1`		`@1 BEDNARCZYK (Robert A.)`
A11	`05`	`1`		`@1 STEINHOFF (Mark C.)`
A11	`06`	`1`		`@1 ADJAYE-GBEWONYO (Dzifa)`
A11	`07`	`1`		`@1 AULT (Kevin)`
A11	`08`	`1`		`@1 GALLAGHER (Mia)`
A11	`09`	`1`		`@1 ORENSTEIN (Walter)`
A11	`10`	`1`		`@1 DAVIS (Robert L.)`
A11	`11`	`1`		`@1 OMER (Saad B.)`
A14	`01`			`@1 Center for Health Research-Southeast, Kaiser Permanente @3 USA @Z 1 aut. @Z 2 aut. @Z 4 aut. @Z 6 aut. @Z 8 aut. @Z 9 aut. @Z 10 aut. @Z 11 aut.`
A14	`02`			`@1 Rollins School of Public Health, Emory University @2 Atlanta, Georgia @3 USA @Z 1 aut. @Z 4 aut. @Z 7 aut. @Z 11 aut.`
A14	`03`			`@1 Mid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic States @2 Rockville, Maryland @3 USA @Z 3 aut.`
A14	`04`			`@1 Cincinnati Children's Hospital Medical Center @2 Cincinnati, Ohio @3 USA @Z 5 aut.`
A14	`05`			`@1 Bloomberg School of Public Health, Johns Hopkins University @2 Baltimore, Maryland @3 USA @Z 5 aut.`
A14	`06`			`@1 School of Medicine, Emory University @2 Atlanta, Georgia @3 USA @Z 7 aut. @Z 11 aut.`
A14	`07`			`@1 Emory Vaccine Center, Emory University @2 Atlanta, Georgia @3 USA @Z 7 aut. @Z 9 aut. @Z 11 aut.`
A20				`@1 1216-1222`
A21				`@1 2013`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 18407 @5 354000500660760040`
A44				`@0 0000 @1 © 2013 INIST-CNRS. All rights reserved.`
A45				`@0 35 ref.`
A47	`01`	`1`		`@0 13-0157683`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Clinical infectious diseases`
A66	`01`			`@0 GBR`
C01	`01`		`ENG`	@0 Background. Influenza infection during pregnancy is associated with adverse fetal outcomes such as preterm birth and small for gestational age (SGA). Maternal influenza immunization may prevent these adverse infant outcomes during periods of influenza circulation. Methods. We conducted a retrospective cohort study of live births within Kaiser Permanente (KP) Georgia and Mid-Atlantic States (n = 3327) during the period of 2009 influenza A (H1N1) virus circulation. Primary outcomes were third-trimester preterm birth (27-36 weeks), birth weight, low birth weight (LBW, <2500 g), and SGA. Results. There were 327 (9.8%) preterm, 236 (7.4%) LBW, and 267 (8.4%) SGA births. Among H1N1-vaccinated mothers (n = 1125), there were 86 (7.6%) preterm, 68 (6.4%) LBW, and 99 (9.3%) SGA births, and the mean birth weight was 3308.5 g (95% confidence interval [CI], 3276.6-3340.4). Among unvaccinated mothers (n = 1581), there were 191 (12.1%) preterm, 132 (8.8%) LBW, and 123 (8.2%) SGA births, and the mean birth weight was 3245.3 g (95% CI, 3216.5-3274.2). Infants of H1N1-vaccinated mothers had 37% lower odds of being born preterm than infants of unvaccinated mothers (adjusted odds ratio, 0.63 [95% CI, .47-.84]). The mean birth weight difference between infants of H1N1-vaccinated mothers and infants of unvaccinated mothers was 45.1 g (95% CI, 1.8-88.3). There was no significant association between maternal H1N1 influenza immunization and LBW or SGA. Conclusions. Pregnant women who received H1N1 influenza vaccine were less likely to give birth preterm, and gave birth to heavier infants. The findings support US vaccine policy choices to prioritize pregnant women during the 2009 influenza A (H1N1) pandemic.
C02	`01`	`X`		`@0 002B05C02C`
C02	`02`	`X`		`@0 002B20F02`
C03	`01`	`X`	`FRE`	`@0 Hypotrophie foetale @2 NM @5 01`
C03	`01`	`X`	`ENG`	`@0 Intrauterine growth retardation @2 NM @5 01`
C03	`01`	`X`	`SPA`	`@0 Hipotrofia fetal @2 NM @5 01`
C03	`02`	`X`	`FRE`	`@0 Poids de naissance faible @5 02`
C03	`02`	`X`	`ENG`	`@0 Low birth weight @5 02`
C03	`02`	`X`	`SPA`	`@0 Peso nacimiento bajo @5 02`
C03	`03`	`X`	`FRE`	`@0 Nouveau né @5 07`
C03	`03`	`X`	`ENG`	`@0 Newborn @5 07`
C03	`03`	`X`	`SPA`	`@0 Recién nacido @5 07`
C03	`04`	`X`	`FRE`	`@0 Pronostic @5 08`
C03	`04`	`X`	`ENG`	`@0 Prognosis @5 08`
C03	`04`	`X`	`SPA`	`@0 Pronóstico @5 08`
C03	`05`	`X`	`FRE`	`@0 Immunisation @5 09`
C03	`05`	`X`	`ENG`	`@0 Immunization @5 09`
C03	`05`	`X`	`SPA`	`@0 Inmunización @5 09`
C03	`06`	`X`	`FRE`	`@0 Vaccination @5 13`
C03	`06`	`X`	`ENG`	`@0 Vaccination @5 13`
C03	`06`	`X`	`SPA`	`@0 Vacunación @5 13`
C03	`07`	`X`	`FRE`	`@0 Prématurité @5 14`
C03	`07`	`X`	`ENG`	`@0 Prematurity @5 14`
C03	`07`	`X`	`SPA`	`@0 Prematuridad @5 14`
C03	`08`	`X`	`FRE`	`@0 Accouchement prématuré @5 15`
C03	`08`	`X`	`ENG`	`@0 Premature delivery @5 15`
C03	`08`	`X`	`SPA`	`@0 Parto prematuro @5 15`
C03	`09`	`X`	`FRE`	`@0 Poids naissance @5 16`
C03	`09`	`X`	`ENG`	`@0 Birth weight @5 16`
C03	`09`	`X`	`SPA`	`@0 Peso nacimiento @5 16`
C03	`10`	`X`	`FRE`	`@0 Naissance @5 17`
C03	`10`	`X`	`ENG`	`@0 Birth @5 17`
C03	`10`	`X`	`SPA`	`@0 Nacimiento @5 17`
C03	`11`	`X`	`FRE`	`@0 Infection @5 18`
C03	`11`	`X`	`ENG`	`@0 Infection @5 18`
C03	`11`	`X`	`SPA`	`@0 Infección @5 18`
C03	`12`	`X`	`FRE`	`@0 Pandémie @4 INC @5 86`
C03	`13`	`X`	`FRE`	`@0 Grippe H1N1 @4 CD @5 96`
C03	`13`	`X`	`ENG`	`@0 H1N1 influenza @4 CD @5 96`
C03	`13`	`X`	`SPA`	`@0 Gripe H1N1 @4 CD @5 96`
C07	`01`	`X`	`FRE`	`@0 Homme`
C07	`01`	`X`	`ENG`	`@0 Human`
C07	`01`	`X`	`SPA`	`@0 Hombre`
C07	`02`	`X`	`FRE`	`@0 Pathologie de l'appareil respiratoire @5 37`
C07	`02`	`X`	`ENG`	`@0 Respiratory disease @5 37`
C07	`02`	`X`	`SPA`	`@0 Aparato respiratorio patología @5 37`
C07	`03`	`X`	`FRE`	`@0 Virose @5 38`
C07	`03`	`X`	`ENG`	`@0 Viral disease @5 38`
C07	`03`	`X`	`SPA`	`@0 Virosis @5 38`
C07	`04`	`X`	`FRE`	`@0 Prévention @5 39`
C07	`04`	`X`	`ENG`	`@0 Prevention @5 39`
C07	`04`	`X`	`SPA`	`@0 Prevención @5 39`
C07	`05`	`X`	`FRE`	`@0 Pathologie de la gestation @5 40`
C07	`05`	`X`	`ENG`	`@0 Pregnancy disorders @5 40`
C07	`05`	`X`	`SPA`	`@0 Gestación patología @5 40`
C07	`06`	`X`	`FRE`	`@0 Pathologie du foetus @5 41`
C07	`06`	`X`	`ENG`	`@0 Fetal diseases @5 41`
C07	`06`	`X`	`SPA`	`@0 Feto patología @5 41`
C07	`07`	`X`	`FRE`	`@0 Pathologie du nouveau né @5 42`
C07	`07`	`X`	`ENG`	`@0 Newborn diseases @5 42`
C07	`07`	`X`	`SPA`	`@0 Recién nacido patología @5 42`
N21				`@1 140`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 13-0157683 INIST
ET :	Neonatal Outcomes After Antenatal Influenza Immunization During the 2009 H1N1 Influenza Pandemic: Impact on Preterm Birth, Birth Weight, and Small for Gestational Age Birth
AU :	RICHARDS (Jennifer L.); HANSEN (Craig); BREDFELDT (Christine); BEDNARCZYK (Robert A.); STEINHOFF (Mark C.); ADJAYE-GBEWONYO (Dzifa); AULT (Kevin); GALLAGHER (Mia); ORENSTEIN (Walter); DAVIS (Robert L.); OMER (Saad B.)
AF :	Center for Health Research-Southeast, Kaiser Permanente/Etats-Unis (1 aut., 2 aut., 4 aut., 6 aut., 8 aut., 9 aut., 10 aut., 11 aut.); Rollins School of Public Health, Emory University/Atlanta, Georgia/Etats-Unis (1 aut., 4 aut., 7 aut., 11 aut.); Mid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic States/Rockville, Maryland/Etats-Unis (3 aut.); Cincinnati Children's Hospital Medical Center/Cincinnati, Ohio/Etats-Unis (5 aut.); Bloomberg School of Public Health, Johns Hopkins University/Baltimore, Maryland/Etats-Unis (5 aut.); School of Medicine, Emory University/Atlanta, Georgia/Etats-Unis (7 aut., 11 aut.); Emory Vaccine Center, Emory University/Atlanta, Georgia/Etats-Unis (7 aut., 9 aut., 11 aut.)
DT :	Publication en série; Niveau analytique
SO :	Clinical infectious diseases; ISSN 1058-4838; Coden CIDIEL; Royaume-Uni; Da. 2013; Vol. 56; No. 9; Pp. 1216-1222; Bibl. 35 ref.
LA :	Anglais
EA :	Background. Influenza infection during pregnancy is associated with adverse fetal outcomes such as preterm birth and small for gestational age (SGA). Maternal influenza immunization may prevent these adverse infant outcomes during periods of influenza circulation. Methods. We conducted a retrospective cohort study of live births within Kaiser Permanente (KP) Georgia and Mid-Atlantic States (n = 3327) during the period of 2009 influenza A (H1N1) virus circulation. Primary outcomes were third-trimester preterm birth (27-36 weeks), birth weight, low birth weight (LBW, <2500 g), and SGA. Results. There were 327 (9.8%) preterm, 236 (7.4%) LBW, and 267 (8.4%) SGA births. Among H1N1-vaccinated mothers (n = 1125), there were 86 (7.6%) preterm, 68 (6.4%) LBW, and 99 (9.3%) SGA births, and the mean birth weight was 3308.5 g (95% confidence interval [CI], 3276.6-3340.4). Among unvaccinated mothers (n = 1581), there were 191 (12.1%) preterm, 132 (8.8%) LBW, and 123 (8.2%) SGA births, and the mean birth weight was 3245.3 g (95% CI, 3216.5-3274.2). Infants of H1N1-vaccinated mothers had 37% lower odds of being born preterm than infants of unvaccinated mothers (adjusted odds ratio, 0.63 [95% CI, .47-.84]). The mean birth weight difference between infants of H1N1-vaccinated mothers and infants of unvaccinated mothers was 45.1 g (95% CI, 1.8-88.3). There was no significant association between maternal H1N1 influenza immunization and LBW or SGA. Conclusions. Pregnant women who received H1N1 influenza vaccine were less likely to give birth preterm, and gave birth to heavier infants. The findings support US vaccine policy choices to prioritize pregnant women during the 2009 influenza A (H1N1) pandemic.
CC :	002B05C02C; 002B20F02
FD :	Hypotrophie foetale; Poids de naissance faible; Nouveau né; Pronostic; Immunisation; Vaccination; Prématurité; Accouchement prématuré; Poids naissance; Naissance; Infection; Pandémie; Grippe H1N1
FG :	Homme; Pathologie de l'appareil respiratoire; Virose; Prévention; Pathologie de la gestation; Pathologie du foetus; Pathologie du nouveau né
ED :	Intrauterine growth retardation; Low birth weight; Newborn; Prognosis; Immunization; Vaccination; Prematurity; Premature delivery; Birth weight; Birth; Infection; H1N1 influenza
EG :	Human; Respiratory disease; Viral disease; Prevention; Pregnancy disorders; Fetal diseases; Newborn diseases
SD :	Hipotrofia fetal; Peso nacimiento bajo; Recién nacido; Pronóstico; Inmunización; Vacunación; Prematuridad; Parto prematuro; Peso nacimiento; Nacimiento; Infección; Gripe H1N1
LO :	INIST-18407.354000500660760040
ID :	13-0157683

Links to Exploration step

Pascal:13-0157683

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Neonatal Outcomes After Antenatal Influenza Immunization During the 2009 H1N1 Influenza Pandemic: Impact on Preterm Birth, Birth Weight, and Small for Gestational Age Birth</title>
<author><name sortKey="Richards, Jennifer L" sort="Richards, Jennifer L" uniqKey="Richards J" first="Jennifer L." last="Richards">Jennifer L. Richards</name>
<affiliation><inist:fA14 i1="01"><s1>Center for Health Research-Southeast, Kaiser Permanente</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Rollins School of Public Health, Emory University</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hansen, Craig" sort="Hansen, Craig" uniqKey="Hansen C" first="Craig" last="Hansen">Craig Hansen</name>
<affiliation><inist:fA14 i1="01"><s1>Center for Health Research-Southeast, Kaiser Permanente</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bredfeldt, Christine" sort="Bredfeldt, Christine" uniqKey="Bredfeldt C" first="Christine" last="Bredfeldt">Christine Bredfeldt</name>
<affiliation><inist:fA14 i1="03"><s1>Mid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic States</s1>
<s2>Rockville, Maryland</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bednarczyk, Robert A" sort="Bednarczyk, Robert A" uniqKey="Bednarczyk R" first="Robert A." last="Bednarczyk">Robert A. Bednarczyk</name>
<affiliation><inist:fA14 i1="01"><s1>Center for Health Research-Southeast, Kaiser Permanente</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Rollins School of Public Health, Emory University</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Steinhoff, Mark C" sort="Steinhoff, Mark C" uniqKey="Steinhoff M" first="Mark C." last="Steinhoff">Mark C. Steinhoff</name>
<affiliation><inist:fA14 i1="04"><s1>Cincinnati Children's Hospital Medical Center</s1>
<s2>Cincinnati, Ohio</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="05"><s1>Bloomberg School of Public Health, Johns Hopkins University</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Adjaye Gbewonyo, Dzifa" sort="Adjaye Gbewonyo, Dzifa" uniqKey="Adjaye Gbewonyo D" first="Dzifa" last="Adjaye-Gbewonyo">Dzifa Adjaye-Gbewonyo</name>
<affiliation><inist:fA14 i1="01"><s1>Center for Health Research-Southeast, Kaiser Permanente</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ault, Kevin" sort="Ault, Kevin" uniqKey="Ault K" first="Kevin" last="Ault">Kevin Ault</name>
<affiliation><inist:fA14 i1="02"><s1>Rollins School of Public Health, Emory University</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="06"><s1>School of Medicine, Emory University</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="07"><s1>Emory Vaccine Center, Emory University</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Gallagher, Mia" sort="Gallagher, Mia" uniqKey="Gallagher M" first="Mia" last="Gallagher">Mia Gallagher</name>
<affiliation><inist:fA14 i1="01"><s1>Center for Health Research-Southeast, Kaiser Permanente</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Orenstein, Walter" sort="Orenstein, Walter" uniqKey="Orenstein W" first="Walter" last="Orenstein">Walter Orenstein</name>
<affiliation><inist:fA14 i1="01"><s1>Center for Health Research-Southeast, Kaiser Permanente</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="07"><s1>Emory Vaccine Center, Emory University</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Davis, Robert L" sort="Davis, Robert L" uniqKey="Davis R" first="Robert L." last="Davis">Robert L. Davis</name>
<affiliation><inist:fA14 i1="01"><s1>Center for Health Research-Southeast, Kaiser Permanente</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Omer, Saad B" sort="Omer, Saad B" uniqKey="Omer S" first="Saad B." last="Omer">Saad B. Omer</name>
<affiliation><inist:fA14 i1="01"><s1>Center for Health Research-Southeast, Kaiser Permanente</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Rollins School of Public Health, Emory University</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="06"><s1>School of Medicine, Emory University</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="07"><s1>Emory Vaccine Center, Emory University</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">13-0157683</idno>
<date when="2013">2013</date>
<idno type="stanalyst">PASCAL 13-0157683 INIST</idno>
<idno type="RBID">Pascal:13-0157683</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000308</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Neonatal Outcomes After Antenatal Influenza Immunization During the 2009 H1N1 Influenza Pandemic: Impact on Preterm Birth, Birth Weight, and Small for Gestational Age Birth</title>
<author><name sortKey="Richards, Jennifer L" sort="Richards, Jennifer L" uniqKey="Richards J" first="Jennifer L." last="Richards">Jennifer L. Richards</name>
<affiliation><inist:fA14 i1="01"><s1>Center for Health Research-Southeast, Kaiser Permanente</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Rollins School of Public Health, Emory University</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hansen, Craig" sort="Hansen, Craig" uniqKey="Hansen C" first="Craig" last="Hansen">Craig Hansen</name>
<affiliation><inist:fA14 i1="01"><s1>Center for Health Research-Southeast, Kaiser Permanente</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bredfeldt, Christine" sort="Bredfeldt, Christine" uniqKey="Bredfeldt C" first="Christine" last="Bredfeldt">Christine Bredfeldt</name>
<affiliation><inist:fA14 i1="03"><s1>Mid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic States</s1>
<s2>Rockville, Maryland</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bednarczyk, Robert A" sort="Bednarczyk, Robert A" uniqKey="Bednarczyk R" first="Robert A." last="Bednarczyk">Robert A. Bednarczyk</name>
<affiliation><inist:fA14 i1="01"><s1>Center for Health Research-Southeast, Kaiser Permanente</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Rollins School of Public Health, Emory University</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Steinhoff, Mark C" sort="Steinhoff, Mark C" uniqKey="Steinhoff M" first="Mark C." last="Steinhoff">Mark C. Steinhoff</name>
<affiliation><inist:fA14 i1="04"><s1>Cincinnati Children's Hospital Medical Center</s1>
<s2>Cincinnati, Ohio</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="05"><s1>Bloomberg School of Public Health, Johns Hopkins University</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Adjaye Gbewonyo, Dzifa" sort="Adjaye Gbewonyo, Dzifa" uniqKey="Adjaye Gbewonyo D" first="Dzifa" last="Adjaye-Gbewonyo">Dzifa Adjaye-Gbewonyo</name>
<affiliation><inist:fA14 i1="01"><s1>Center for Health Research-Southeast, Kaiser Permanente</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ault, Kevin" sort="Ault, Kevin" uniqKey="Ault K" first="Kevin" last="Ault">Kevin Ault</name>
<affiliation><inist:fA14 i1="02"><s1>Rollins School of Public Health, Emory University</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="06"><s1>School of Medicine, Emory University</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="07"><s1>Emory Vaccine Center, Emory University</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Gallagher, Mia" sort="Gallagher, Mia" uniqKey="Gallagher M" first="Mia" last="Gallagher">Mia Gallagher</name>
<affiliation><inist:fA14 i1="01"><s1>Center for Health Research-Southeast, Kaiser Permanente</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Orenstein, Walter" sort="Orenstein, Walter" uniqKey="Orenstein W" first="Walter" last="Orenstein">Walter Orenstein</name>
<affiliation><inist:fA14 i1="01"><s1>Center for Health Research-Southeast, Kaiser Permanente</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="07"><s1>Emory Vaccine Center, Emory University</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Davis, Robert L" sort="Davis, Robert L" uniqKey="Davis R" first="Robert L." last="Davis">Robert L. Davis</name>
<affiliation><inist:fA14 i1="01"><s1>Center for Health Research-Southeast, Kaiser Permanente</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Omer, Saad B" sort="Omer, Saad B" uniqKey="Omer S" first="Saad B." last="Omer">Saad B. Omer</name>
<affiliation><inist:fA14 i1="01"><s1>Center for Health Research-Southeast, Kaiser Permanente</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Rollins School of Public Health, Emory University</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="06"><s1>School of Medicine, Emory University</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="07"><s1>Emory Vaccine Center, Emory University</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Clinical infectious diseases</title>
<title level="j" type="abbreviated">Clin. infect. dis.</title>
<idno type="ISSN">1058-4838</idno>
<imprint><date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Clinical infectious diseases</title>
<title level="j" type="abbreviated">Clin. infect. dis.</title>
<idno type="ISSN">1058-4838</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Birth</term>
<term>Birth weight</term>
<term>H1N1 influenza</term>
<term>Immunization</term>
<term>Infection</term>
<term>Intrauterine growth retardation</term>
<term>Low birth weight</term>
<term>Newborn</term>
<term>Premature delivery</term>
<term>Prematurity</term>
<term>Prognosis</term>
<term>Vaccination</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Hypotrophie foetale</term>
<term>Poids de naissance faible</term>
<term>Nouveau né</term>
<term>Pronostic</term>
<term>Immunisation</term>
<term>Vaccination</term>
<term>Prématurité</term>
<term>Accouchement prématuré</term>
<term>Poids naissance</term>
<term>Naissance</term>
<term>Infection</term>
<term>Pandémie</term>
<term>Grippe H1N1</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Background. Influenza infection during pregnancy is associated with adverse fetal outcomes such as preterm birth and small for gestational age (SGA). Maternal influenza immunization may prevent these adverse infant outcomes during periods of influenza circulation. Methods. We conducted a retrospective cohort study of live births within Kaiser Permanente (KP) Georgia and Mid-Atlantic States (n = 3327) during the period of 2009 influenza A (H1N1) virus circulation. Primary outcomes were third-trimester preterm birth (27-36 weeks), birth weight, low birth weight (LBW, <2500 g), and SGA. Results. There were 327 (9.8%) preterm, 236 (7.4%) LBW, and 267 (8.4%) SGA births. Among H1N1-vaccinated mothers (n = 1125), there were 86 (7.6%) preterm, 68 (6.4%) LBW, and 99 (9.3%) SGA births, and the mean birth weight was 3308.5 g (95% confidence interval [CI], 3276.6-3340.4). Among unvaccinated mothers (n = 1581), there were 191 (12.1%) preterm, 132 (8.8%) LBW, and 123 (8.2%) SGA births, and the mean birth weight was 3245.3 g (95% CI, 3216.5-3274.2). Infants of H1N1-vaccinated mothers had 37% lower odds of being born preterm than infants of unvaccinated mothers (adjusted odds ratio, 0.63 [95% CI, .47-.84]). The mean birth weight difference between infants of H1N1-vaccinated mothers and infants of unvaccinated mothers was 45.1 g (95% CI, 1.8-88.3). There was no significant association between maternal H1N1 influenza immunization and LBW or SGA. Conclusions. Pregnant women who received H1N1 influenza vaccine were less likely to give birth preterm, and gave birth to heavier infants. The findings support US vaccine policy choices to prioritize pregnant women during the 2009 influenza A (H1N1) pandemic.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>1058-4838</s0>
</fA01>
<fA02 i1="01"><s0>CIDIEL</s0>
</fA02>
<fA03 i2="1"><s0>Clin. infect. dis.</s0>
</fA03>
<fA05><s2>56</s2>
</fA05>
<fA06><s2>9</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Neonatal Outcomes After Antenatal Influenza Immunization During the 2009 H1N1 Influenza Pandemic: Impact on Preterm Birth, Birth Weight, and Small for Gestational Age Birth</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>RICHARDS (Jennifer L.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>HANSEN (Craig)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>BREDFELDT (Christine)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>BEDNARCZYK (Robert A.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>STEINHOFF (Mark C.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>ADJAYE-GBEWONYO (Dzifa)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>AULT (Kevin)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>GALLAGHER (Mia)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>ORENSTEIN (Walter)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>DAVIS (Robert L.)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>OMER (Saad B.)</s1>
</fA11>
<fA14 i1="01"><s1>Center for Health Research-Southeast, Kaiser Permanente</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Rollins School of Public Health, Emory University</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Mid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic States</s1>
<s2>Rockville, Maryland</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Cincinnati Children's Hospital Medical Center</s1>
<s2>Cincinnati, Ohio</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Bloomberg School of Public Health, Johns Hopkins University</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>School of Medicine, Emory University</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Emory Vaccine Center, Emory University</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</fA14>
<fA20><s1>1216-1222</s1>
</fA20>
<fA21><s1>2013</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>18407</s2>
<s5>354000500660760040</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2013 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>35 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>13-0157683</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Clinical infectious diseases</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Background. Influenza infection during pregnancy is associated with adverse fetal outcomes such as preterm birth and small for gestational age (SGA). Maternal influenza immunization may prevent these adverse infant outcomes during periods of influenza circulation. Methods. We conducted a retrospective cohort study of live births within Kaiser Permanente (KP) Georgia and Mid-Atlantic States (n = 3327) during the period of 2009 influenza A (H1N1) virus circulation. Primary outcomes were third-trimester preterm birth (27-36 weeks), birth weight, low birth weight (LBW, <2500 g), and SGA. Results. There were 327 (9.8%) preterm, 236 (7.4%) LBW, and 267 (8.4%) SGA births. Among H1N1-vaccinated mothers (n = 1125), there were 86 (7.6%) preterm, 68 (6.4%) LBW, and 99 (9.3%) SGA births, and the mean birth weight was 3308.5 g (95% confidence interval [CI], 3276.6-3340.4). Among unvaccinated mothers (n = 1581), there were 191 (12.1%) preterm, 132 (8.8%) LBW, and 123 (8.2%) SGA births, and the mean birth weight was 3245.3 g (95% CI, 3216.5-3274.2). Infants of H1N1-vaccinated mothers had 37% lower odds of being born preterm than infants of unvaccinated mothers (adjusted odds ratio, 0.63 [95% CI, .47-.84]). The mean birth weight difference between infants of H1N1-vaccinated mothers and infants of unvaccinated mothers was 45.1 g (95% CI, 1.8-88.3). There was no significant association between maternal H1N1 influenza immunization and LBW or SGA. Conclusions. Pregnant women who received H1N1 influenza vaccine were less likely to give birth preterm, and gave birth to heavier infants. The findings support US vaccine policy choices to prioritize pregnant women during the 2009 influenza A (H1N1) pandemic.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B05C02C</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B20F02</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Hypotrophie foetale</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Intrauterine growth retardation</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Hipotrofia fetal</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Poids de naissance faible</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Low birth weight</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Peso nacimiento bajo</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Nouveau né</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Newborn</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Recién nacido</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Pronostic</s0>
<s5>08</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Prognosis</s0>
<s5>08</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Pronóstico</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Immunisation</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Immunization</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Inmunización</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Vaccination</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Vaccination</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Vacunación</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Prématurité</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Prematurity</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Prematuridad</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Accouchement prématuré</s0>
<s5>15</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Premature delivery</s0>
<s5>15</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Parto prematuro</s0>
<s5>15</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Poids naissance</s0>
<s5>16</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Birth weight</s0>
<s5>16</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Peso nacimiento</s0>
<s5>16</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Naissance</s0>
<s5>17</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Birth</s0>
<s5>17</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Nacimiento</s0>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Infection</s0>
<s5>18</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Infection</s0>
<s5>18</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Infección</s0>
<s5>18</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Pandémie</s0>
<s4>INC</s4>
<s5>86</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Grippe H1N1</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>H1N1 influenza</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Gripe H1N1</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Homme</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Human</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Hombre</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Pathologie de l'appareil respiratoire</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Respiratory disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Aparato respiratorio patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Virose</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Viral disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Virosis</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Prévention</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Prevention</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Prevención</s0>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Pathologie de la gestation</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Pregnancy disorders</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Gestación patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Pathologie du foetus</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Fetal diseases</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Feto patología</s0>
<s5>41</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Pathologie du nouveau né</s0>
<s5>42</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Newborn diseases</s0>
<s5>42</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Recién nacido patología</s0>
<s5>42</s5>
</fC07>
<fN21><s1>140</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 13-0157683 INIST</NO>
<ET>Neonatal Outcomes After Antenatal Influenza Immunization During the 2009 H1N1 Influenza Pandemic: Impact on Preterm Birth, Birth Weight, and Small for Gestational Age Birth</ET>
<AU>RICHARDS (Jennifer L.); HANSEN (Craig); BREDFELDT (Christine); BEDNARCZYK (Robert A.); STEINHOFF (Mark C.); ADJAYE-GBEWONYO (Dzifa); AULT (Kevin); GALLAGHER (Mia); ORENSTEIN (Walter); DAVIS (Robert L.); OMER (Saad B.)</AU>
<AF>Center for Health Research-Southeast, Kaiser Permanente/Etats-Unis (1 aut., 2 aut., 4 aut., 6 aut., 8 aut., 9 aut., 10 aut., 11 aut.); Rollins School of Public Health, Emory University/Atlanta, Georgia/Etats-Unis (1 aut., 4 aut., 7 aut., 11 aut.); Mid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic States/Rockville, Maryland/Etats-Unis (3 aut.); Cincinnati Children's Hospital Medical Center/Cincinnati, Ohio/Etats-Unis (5 aut.); Bloomberg School of Public Health, Johns Hopkins University/Baltimore, Maryland/Etats-Unis (5 aut.); School of Medicine, Emory University/Atlanta, Georgia/Etats-Unis (7 aut., 11 aut.); Emory Vaccine Center, Emory University/Atlanta, Georgia/Etats-Unis (7 aut., 9 aut., 11 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Clinical infectious diseases; ISSN 1058-4838; Coden CIDIEL; Royaume-Uni; Da. 2013; Vol. 56; No. 9; Pp. 1216-1222; Bibl. 35 ref.</SO>
<LA>Anglais</LA>
<EA>Background. Influenza infection during pregnancy is associated with adverse fetal outcomes such as preterm birth and small for gestational age (SGA). Maternal influenza immunization may prevent these adverse infant outcomes during periods of influenza circulation. Methods. We conducted a retrospective cohort study of live births within Kaiser Permanente (KP) Georgia and Mid-Atlantic States (n = 3327) during the period of 2009 influenza A (H1N1) virus circulation. Primary outcomes were third-trimester preterm birth (27-36 weeks), birth weight, low birth weight (LBW, <2500 g), and SGA. Results. There were 327 (9.8%) preterm, 236 (7.4%) LBW, and 267 (8.4%) SGA births. Among H1N1-vaccinated mothers (n = 1125), there were 86 (7.6%) preterm, 68 (6.4%) LBW, and 99 (9.3%) SGA births, and the mean birth weight was 3308.5 g (95% confidence interval [CI], 3276.6-3340.4). Among unvaccinated mothers (n = 1581), there were 191 (12.1%) preterm, 132 (8.8%) LBW, and 123 (8.2%) SGA births, and the mean birth weight was 3245.3 g (95% CI, 3216.5-3274.2). Infants of H1N1-vaccinated mothers had 37% lower odds of being born preterm than infants of unvaccinated mothers (adjusted odds ratio, 0.63 [95% CI, .47-.84]). The mean birth weight difference between infants of H1N1-vaccinated mothers and infants of unvaccinated mothers was 45.1 g (95% CI, 1.8-88.3). There was no significant association between maternal H1N1 influenza immunization and LBW or SGA. Conclusions. Pregnant women who received H1N1 influenza vaccine were less likely to give birth preterm, and gave birth to heavier infants. The findings support US vaccine policy choices to prioritize pregnant women during the 2009 influenza A (H1N1) pandemic.</EA>
<CC>002B05C02C; 002B20F02</CC>
<FD>Hypotrophie foetale; Poids de naissance faible; Nouveau né; Pronostic; Immunisation; Vaccination; Prématurité; Accouchement prématuré; Poids naissance; Naissance; Infection; Pandémie; Grippe H1N1</FD>
<FG>Homme; Pathologie de l'appareil respiratoire; Virose; Prévention; Pathologie de la gestation; Pathologie du foetus; Pathologie du nouveau né</FG>
<ED>Intrauterine growth retardation; Low birth weight; Newborn; Prognosis; Immunization; Vaccination; Prematurity; Premature delivery; Birth weight; Birth; Infection; H1N1 influenza</ED>
<EG>Human; Respiratory disease; Viral disease; Prevention; Pregnancy disorders; Fetal diseases; Newborn diseases</EG>
<SD>Hipotrofia fetal; Peso nacimiento bajo; Recién nacido; Pronóstico; Inmunización; Vacunación; Prematuridad; Parto prematuro; Peso nacimiento; Nacimiento; Infección; Gripe H1N1</SD>
<LO>INIST-18407.354000500660760040</LO>
<ID>13-0157683</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000308 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000308 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:13-0157683
   |texte=   Neonatal Outcomes After Antenatal Influenza Immunization During the 2009 H1N1 Influenza Pandemic: Impact on Preterm Birth, Birth Weight, and Small for Gestational Age Birth
}}

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021

	Serveur d'exploration sur les pandémies grippales
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les pandémies grippales

Neonatal Outcomes After Antenatal Influenza Immunization During the 2009 H1N1 Influenza Pandemic: Impact on Preterm Birth, Birth Weight, and Small for Gestational Age Birth

Neonatal Outcomes After Antenatal Influenza Immunization During the 2009 H1N1 Influenza Pandemic: Impact on Preterm Birth, Birth Weight, and Small for Gestational Age Birth

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri